Pharmaceutical giant Eli Lilly is doubling its investments in a new plant in the state of Indiana. This move is in response ...
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection ...
Pharmaceutical giant Eli Lilly opened its new Concord, NC, facility on Friday. The company has invested more than $2 billion ...
Governor Roy Coope, Eli Lilly officials and others were on hand as the new $2 billion facility opened on Concord Friday, June ...
North Carolina Governor Roy Cooper is in Concord Friday for the ribbon-cutting ceremony of pharmaceutical company Eli Lilly’s ...
Advancing a strategy several years in the making, Purdue University trustees on Friday (June 7) endorsed the launch of the ...
INDIANAPOLIS — From the Discovery Park District in West Lafayette to the heart of downtown Indianapolis, America’s Hard-Tech ...
Eli Lilly's stock has seen significant gains due to the success of its GLP-1 franchise and the potential of donanemab for Alzheimer's disease. The FDA's Advisory Committee endorsed donanemab for ...
Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
An FDA advisory committee voted 11-0 in favor of Eli Lilly and Company's donanemab for the treatment of early Alzheimer's disease. Donanemab has no effect on non-APOE4 carriers, may slow the ...
Eli Lilly has more work it wants to do with the hard-won success from its weight loss and diabetes drugs, Zepbound and Mounjaro, outgoing CFO Anat Ashkenazi told CNBC. The company is working to ...